BINNOPHARM

Binnopharm JSC is one of the largest Russian full-cycle biopharmaceutical companies with its own R&D division. The Binnopharm company develops and produces biotechnological genetically engineered drugs, including the hepatitis B vaccine, in full compliance with international GMP quality standards, and carries out the production and wholesale of drugs and pharmaceutical substances. 74% of the authorized capital of the company belongs to AFK Sistema.